BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35668201)

  • 1. Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study.
    Nguyen M; LeWitt T; Pang Y; Bagnowski K; Espinosa ML; Choi J; Guitart J; Liszewski W; Zhou XA
    Arch Dermatol Res; 2023 Mar; 315(2):275-278. PubMed ID: 35668201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical exposures and demographic associations in cutaneous T-cell lymphoma: a large single institution physician validated cohort study.
    Ren Z; Chrisman LP; Pang Y; Nguyen M; Hooper MJ; LeWitt TM; Veon FL; Guitart J; Zhou XA
    Arch Dermatol Res; 2024 Jan; 316(2):74. PubMed ID: 38236413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
    Molloy K; Jonak C; Woei-A-Jin FJSH; Guenova E; Busschots AM; Bervoets A; Hauben E; Knobler R; Porkert S; Fassnacht C; Cowan R; Papadavid E; Beylot-Barry M; Berti E; Alberti Violetti S; Estrach T; Matin R; Akilov O; Vakeva L; Prince M; Bates A; Bayne M; Wachsmuch R; Wehkamp U; Marschalko M; Servitje O; Turner D; Weatherhead S; Wobser M; Sanches JA; McKay P; Klemke D; Peng C; Howles A; Yoo J; Evison F; Scarisbrick J
    Br J Dermatol; 2020 Mar; 182(3):770-779. PubMed ID: 31049926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
    J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and severity of pruritus in cutaneous T cell lymphoma.
    Vij A; Duvic M
    Int J Dermatol; 2012 Aug; 51(8):930-4. PubMed ID: 22788808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator.
    Ottevanger R; van Beugen S; Evers AWM; Willemze R; Vermeer MH; Quint KD
    JAAD Int; 2022 Dec; 9():57-64. PubMed ID: 36147217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical severity measures and quality-of-life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology-specific instruments.
    Herbosa CM; Semenov YR; Rosenberg AR; Mehta-Shah N; Musiek AC
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):995-1003. PubMed ID: 31630443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
    Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
    Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and severity of pruritus and quality of life in patients with cutaneous T-cell lymphoma.
    Wright A; Wijeratne A; Hung T; Gao W; Whittaker S; Morris S; Scarisbrick J; Beynon T
    J Pain Symptom Manage; 2013 Jan; 45(1):114-9. PubMed ID: 22917715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma.
    Hu M; Scheffel J; Elieh-Ali-Komi D; Maurer M; Hawro T; Metz M
    Clin Exp Med; 2023 Dec; 23(8):4177-4197. PubMed ID: 37555911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage.
    Navarro Matilla B; Ortiz Romero PL; Pujol Vallverdú RM; Combalia Escudero A; Zapata Paz I; González Barca E; Muniesa Montserrat C; Morillo Andújar M; Pérez Ferriols A; Román Curto C; Fernández de Misa Cabrera R; Hospital Gil M; Marín Niebla A; Rios Rull PJ; de la Cruz Vicente F; Izu Belloso RM; Martín García-Sancho A; Parera Amer ME; Córdoba Mascuñano R; Ramón Quiles MD; Saus Carreres A; Del Campo García R; Machan S; Viguera Ester P; Blanco Garnelo J
    Actas Dermosifiliogr; 2024 Feb; 115(2):119-129. PubMed ID: 37689349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acitretin for the treatment of cutaneous T-cell lymphoma.
    Cheeley J; Sahn RE; DeLong LK; Parker SR
    J Am Acad Dermatol; 2013 Feb; 68(2):247-54. PubMed ID: 22917895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature.
    Ottevanger R; van Beugen S; Evers AWM; Willemze R; Vermeer MH; Quint KD
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):2377-2387. PubMed ID: 34331819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.
    Pruksaeakanan C; Teyateeti P; Patthamalai P; Thumrongtharadol J; Chairatchaneeboon M
    Biomed Res Int; 2021; 2021():4057661. PubMed ID: 34235215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
    Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
    Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.